Gå direkt till huvudinnehållet

Meningit

Senast uppdaterad: Senast reviderad:
Sakkunnig:
Definition:
Akut bakteriell meningit (ABM) är en infektion i hjärnhinnorna och tilhörande CNS-strukturer. 
Förekomst:
Årligen diagnostiseras under 100 fall i Sverige. Fallen är oftast sporadiska. 
Symtom:
Klassiska symtom är hög feber, huvudvärk och nackstyvhet, men dessa kan också saknas.
Kliniska fynd:
Vid meningokocksjukdom kan petekier ses. Fyndet är förenligt med sepsis. Eventuellt ses nackstyvhet.  
Diagnostik:
Lumbalpunktion är den viktigaste diagnostiska åtgärden. 
Behandling:
Viktigaste behandlingsåtgärden är omedelbar empirisk och därefter riktad adekvat antibiotikabehandling. Allvarliga utfall är vanligt vid ABM.
  1. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007; 369: 2196-210. PubMed  
  2. Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis 2010;10: 32-42. PubMed  
  3. Van de Beek D, Drake JM, Tunkel AR. Nosokomial Bacterial Meningitis. N Engl J Med 2010;362:146. New England Journal of Medicine  
  4. Svenska Infektionsläkarföreningens nationella vårdprogram: Bakteriella CNS-infektioner. Avser vuxna patienter med akut bakteriell meningit, neurokirurgisk infektion, tuberkulös meningit, hjärnabscess och neuroborrelios. Reviderat 2020. infektion.net  
  5. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States 1998-2007. N Engl J Med 2011; 364: 2016.
  6. Neisseria meningitidis - Årsrapport över invasiv meningokockinfektion i Sverige år 2016 . Universitetssjukhuset Örebro.
  7. GBD 2016 Meningitis Collaborators. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, Neurology 2018. doi::https://doi.org/10.1016/S1474-4422(18)30387-9
  8. Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis 2014; 14: 813. pmid:25104307 PubMed  
  9. McIntyre PB, O'Brien KL, Greenwood B. Effect of vaccines on bacterial meningitis worldwide. Lancet 2012; 380: 1703. pmid:23141619 PubMed  
  10. Watt JP, Wolfson LJ, O`Brien KL, et al: Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009; 374: 903.
  11. Ifeanyichukwu OO, Johnson AP, Henderson KL. Incidence, Etiology, and Outcome of Bacterial Meningitis in INfants Aged <90 Days in the United Kingdom and Republic of Ireland: Prospective, Enhanced, Nation Population-Based Surveillance. Clin Infect Dis 2014; 59: e150. pmid:24997051 PubMed  
  12. Peltola H. Worldwide H influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13: 302-17. PubMed  
  13. Watt JP, Wolfson LJ, O`Brien KL, et al. Burden of disease caused by Haemophilus influenzae type b in chikdren younger than 5 years: global estimates. Lancet 2009; 374: 903-11. PubMed  
  14. Dando SJ, Mackay-SIM A, Norton R. Pathogens Penetrating the Central Nervous System: Infection Pathways and the Cellular and Molecular Mechanisms of Invasion. Clin Microbiol Rev 2014; 27: 691. pmid:25278572 PubMed  
  15. Yazdankhah SP and Caugant D. Neisseria meningitidis: An overview of the carriage state. J Med Microbiol 2004; 53: 821-32. PubMed  
  16. Stephens DS. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet 1999; 353: 941-2. PubMed  
  17. Goldschneider I, Gotschlich EC and Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies, J Exp Med 1969; 129: 1307-26.
  18. Øvstebø R, Brandtzaeg P, Brusletto B, et al. Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 2004; 42: 2980-7. PubMed  
  19. Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299 :2056. www.ncbi.nlm.nih.gov  
  20. Reis O, Sousa S, Camejo A, et al. LapB, a novel Listeria monocytogenes LPXTG surface adhesin, required for entry into eukaryotic cells and virulence. J Infect Dis. 2010; 202: 551.
  21. Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127: 817.
  22. Van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849-59.
  23. Nudelman Y, Tunkel AR. Bacterial Meningitis. Drugs 2009; 69: 2577.
  24. Första fallen av miyamotoi-borrelios med meningit i Sverige. Thomas G T Jaenson. Läkartidningen. 2019;116:FUET
  25. De Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347:1549.
  26. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993;328:21.
  27. Antal EA, Dietrichs E, Løberg EM, et al. Brain stem encephalitis in listeriosis. Scand J Infect Dis 2005;37:190.
  28. Pong A, Bradley JS . Bacterial meningitis and the newborn infant. Infect Dis Clin North Am 1999;13:711.
  29. Thompson MI, Ninis N, Perera R et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006; 367: 397-403. PubMed  
  30. Straus SE, Thorpe KE, Holroyd-Leduc J. How do I perform a lumbar puncture and analyze the results to diagnose bacterial meningitis? JAMA 2006; 296: 2012-22. Journal of the American Medical Association  
  31. Theilen U, Wilson L, Wilson G, Beattie JO et al. Management of invasive meningococcal disease in children and young people: summary of SIGN guidelines . BMJ 2008; 336: 1367-70. PubMed  
  32. van Crevel H, Hijdra A, de Gans J. Lumbar puncture and the risk of herniation: when should we first perform CT? J Neurol 2002; 249: 129-37. PubMed  
  33. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345: 1727-33. New England Journal of Medicine  
  34. Proulx N, Frechette D, Toye B, Chan J, Kravcik S. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005; 98: 291-8. PubMed  
  35. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351: 1849-59. New England Journal of Medicine  
  36. Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute meningitis: an analysis of the predictive value of initial observations. JAMA 1989; 262: 2700-7. Journal of the American Medical Association  
  37. Diggle MA and Clarke SC. Molecular methods for the detection and characterization of Neisseria meningitidis. Expert Rev Mol Diagn 2006; 6: 79-87. PubMed  
  38. Kanegaye JT, Soliemanzadeh P and Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics ; 2001; 108: 1169-74
  39. van de Beek D, de Gans J, Spanjaard L, Vermeulen M, Dankert J. Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother 2002; 49: 661-6. PubMed  
  40. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39: 1267-84. PubMed  
  41. Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;9:CD004405. The Cochrane Library  
  42. Ogunlesi TA, Odigwe CC, Oladapo OT. Use of corticosteroids for treatment of the newborn with bacterial meningitis. Cochrane Database of Systematic Reviews 2015. doi: 10.1002/14651858.CD010435.pub2. DOI  
  43. Brouwer MC, Tunkel AR, McKhann GM. Brain abscess. New Engl J Med 2014; 371: 447. pmid:25075836 PubMed  
  44. Trotter CL, Andrews NJ, Kaczmarski EB, Miller E and Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004; 364: 365-7. PubMed  
  45. Snape MD and Pollard AJ. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis 2005; 5: 21-30. PubMed  
  46. Kaplan SL. Clinical manifestations, diagnosis, and prognostic factors of bacterial meningitis. Infect Dis Clin North Am 1999; 13: 579-90. PubMed  
  47. Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ 2001; 323: 533. PubMed  
  48. Flexner S. The results of the serum treatment in thirteen hundred cases of epidemic meningitis. J Exp Med 1913; 17: 553-76. PubMed  
  49. Ifeanyichukwu OO, Johnson AP, Henderson KL.. Incidence, Etiology, and Outcome of Bacterial Meningitis in INfants Aged <90 Days in the United Kingdom and Republic of Ireland: Prospective, Enhanced, Nation Population-Based Surveillance. . Clin Infect Di 2014; 59: e150. pmid:24997051 PubMed  
  • Athena Adeli, legitimerad läkare, Karolinska Institutet

Tidigare sakkunniga

  • Bertil Christensson, professor och överläkare, Infektionskliniken, Skånes universitetssjukhus